A Phase Ii Clinical Trial Of A Novel Combinatorial Antitumor Immunotherapy For Patients With High-Risk Resected Stage Iii And Metastatic Melanoma.
JOURNAL OF CLINICAL ONCOLOGY(2010)
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要
JOURNAL OF CLINICAL ONCOLOGY(2010)